Evidence map›Paper›PMID 34327664›Full record

ReviewAdvances in experimental medicine and biology2022

From Cells to Organs: The Present and Future of Regenerative Medicine.

Yichen Wang, Yoon-Young Jang

Abstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yichen WangDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Yoon-Young JangDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. yjang3@jhmi.edu.

Funding

Developing preclinical human iPSC-based HTS assays to identify therapeutic agents for biliary atresiaR01DK122982 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI JANG, YOON YOUNG · 2020 to 2022
$1.1M
NIDDK NIH HHS R01 DK122982
6 · The paper itself

Abstract

Regenerative medicine promises a bright future where damaged body parts can be restored, rejuvenated, and replaced. The application of regenerative medicine is interdisciplinary and covers nearly all fields of medical sciences and molecular engineering. This review provides a road map on how regenerative medicine is applied on the levels of cell, tissue, and organ and summarizes the advantages and limitation of human pluripotent stem cells in disease modeling and regenerative application.

Indexed as

Pluripotent Stem CellsRegenerative MedicineHumansTissue EngineeringCartilage damageHepatobiliary disease modelingKidney dysfunctionOrganoidsPluripotent stem cellsRegenerative medicineSickle cell disease

Identifiers

PMID34327664
PMCPMC9301257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.